Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

NCT01426880 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

595

Enrollment

OTHER

Sponsor class

Conditions

Tubular Breast Cancer Stage II
Mucinous Breast Cancer Stage II
Breast Cancer Female NOS
Invasive Ductal Breast Cancer
Tubular Breast Cancer Stage III
HER-2 Positive Breast Cancer
Inflammatory Breast Cancer Stage IV
Inflammatory Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: background treatment

Sponsor

GBG Forschungs GmbH

Collaborators

[object Object]
[object Object]
[object Object]